tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

COYA Stock Latest News

Coya Therapeutics files to sell 1.38M shares of common stock for holders
The FlyCoya Therapeutics files to sell 1.38M shares of common stock for holders
1d ago
COYA
Coya: COYA 301 – GLP-1 agonists combo synergistic in inflamation amelioration
PremiumThe Fly
Coya: COYA 301 – GLP-1 agonists combo synergistic in inflamation amelioration
3d ago
COYA
Coya Therapeutics Reports Q3 2024 Highlights and Progress
PremiumCompany Announcements
Coya Therapeutics Reports Q3 2024 Highlights and Progress
15d ago
COYA
Coya Therapeutics Advances Pipeline for Neurodegenerative Diseases
PremiumCompany Announcements
Coya Therapeutics Advances Pipeline for Neurodegenerative Diseases
16d ago
8K
COYA
Coya Therapeutics reports Q3 EPS (26c), consensus (41c)
PremiumThe Fly
Coya Therapeutics reports Q3 EPS (26c), consensus (41c)
16d ago
COYA
Coya Therapeutics Announces Leadership Change and New CEO
PremiumCompany AnnouncementsCoya Therapeutics Announces Leadership Change and New CEO
21d ago
8K
COYA
Coya Therapeutics Reports Positive Phase 2 Alzheimer’s Trial Results
Premium
Company Announcements
Coya Therapeutics Reports Positive Phase 2 Alzheimer’s Trial Results
24d ago
8K
COYA
Coya Therapeutics says Phase 2 LD-1L-2 study met primary, secondary endpoints
Premium
The Fly
Coya Therapeutics says Phase 2 LD-1L-2 study met primary, secondary endpoints
24d ago
COYA
Coya Therapeutics Announces $10M Private Placement to Advance Pipeline
PremiumCompany Announcements
Coya Therapeutics Announces $10M Private Placement to Advance Pipeline
1M ago
8K
COYA
Coya Therapeutics to sell 1.379M shares at $7.25 in private placement
PremiumThe Fly
Coya Therapeutics to sell 1.379M shares at $7.25 in private placement
1M ago
COYA
Coya Therapeutics announces direct CNS anti-inflammatory effect of COYA 302
PremiumThe Fly
Coya Therapeutics announces direct CNS anti-inflammatory effect of COYA 302
2M ago
COYA
Coya Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Coya Therapeutics initiated with a Buy at H.C. Wainwright
2M ago
COYA
Coya Therapeutics CEO Howard Berman to leave role, Arun Swaminathan to succeed
PremiumThe FlyCoya Therapeutics CEO Howard Berman to leave role, Arun Swaminathan to succeed
3M ago
COYA
Coya Therapeutics reports Q2 EPS (19c), consensus (31c)
Premium
The Fly
Coya Therapeutics reports Q2 EPS (19c), consensus (31c)
3M ago
COYA
Coya files U.S patents for COYA 301 + GLP-1 receptor agonists
Premium
The Fly
Coya files U.S patents for COYA 301 + GLP-1 receptor agonists
4M ago
COYA
Coya Therapeutics expands sponsored research collaboration with HMRI
PremiumThe Fly
Coya Therapeutics expands sponsored research collaboration with HMRI
5M ago
COYA
Coya Therapeutics files to sell 603,136 shares of common stock for holders
PremiumThe Fly
Coya Therapeutics files to sell 603,136 shares of common stock for holders
5M ago
COYA
Coya Therapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Coya Therapeutics initiated with a Buy at Rodman & Renshaw
5M ago
COYA
Coya publishes ALS study in peer-reviewed Frontiers in Neurology
PremiumThe Fly
Coya publishes ALS study in peer-reviewed Frontiers in Neurology
5M ago
COYA
Coya completes of Phase 2 study of LD IL-2 to treat moderate AD
PremiumThe FlyCoya completes of Phase 2 study of LD IL-2 to treat moderate AD
6M ago
COYA
Coya Therapeutics announces $5M strategic investment from ADDF
Premium
The Fly
Coya Therapeutics announces $5M strategic investment from ADDF
6M ago
COYA
Coya Therapeutics Financial and Operational Results Overview
Premium
Company Announcements
Coya Therapeutics Financial and Operational Results Overview
7M ago
8K
COYA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >